Diabetic retinopathy (DR) is a leading cause of vision loss among working-age adults in the United States. However, despite the critical need for regular screenings to detect the condition early, traditional specialist screenings face barriers such as long waiting times, high costs due to the need for an eye specialist, and the inconvenience of pupil dilation, which often discourage patients from undergoing these essential annual exams.
AEYE-DS is the only solution that addresses these challenges as the only FDA-cleared AI for a portable camera, and the only AI featuring a one-minute, on-the-spot diagnostic exam that does not require physician interpretation. It can be conveniently conducted anywhere, especially in primary care settings by any clinic staff member. Its streamlined, AI-based solution integrates effortlessly into clinics, simplifying implementation. With its ease of use, compatibility with Electronic Medical Records (EMR), CPT code for reimbursement, and automated billing and reporting features, AEYE-DS offers numerous advantages for conducting screenings directly within primary care, enhancing both patient care and practice efficiency.
Ease of Use and Integration with Existing Workflows
Implementing new technology in a busy primary care clinic can seem daunting, but AEYE-DS is designed to be both straightforward and user-friendly. The FDA-cleared solution requires minimal training, allowing any healthcare professional in your clinic to perform the screening. The process is swift, taking just one minute with a single image per eye, without pupil dilation. With AI providing instant diagnostic results, and the option to use either a portable handheld device or a robotic tabletop camera, AEYE-DS offers flexibility for any setting. This simplicity ensures that screenings are completed efficiently, while patients wait to see their physician allowing for immediate discussion of results and follow-up, as needed.
AEYE-DS integrates seamlessly with clinic EMR systems, generating alerts for care gaps and ensuring that screenings are completed. Once the screening is finished, results are automatically uploaded to the patient’s electronic health record. This eliminates manual data entry, minimizes the risk of transcription errors, and makes all relevant information easily accessible to the treating physician. This integration not only streamlines workflow but also enhances clinical decision-making and supports personalized patient care.
Automated Billing and Reporting: Simplifying Reimbursement
Billing can be complex and time-consuming, but AEYE-DS simplifies the process with automated billing and reporting. The system automatically generates the necessary documentation for reimbursement, including CPT code 92229, which covers autonomous diabetic retinopathy screenings in primary care. With a national average reimbursement rate of approximately $50, this makes AEYE-DS a financially viable option for clinics. Moreover, increased reporting of diabetic eye exams helps close the comprehensive diabetes care HEDIS measure and enhances star ratings, further benefiting your practice.
Moreover, since the entire AEYE-DS exam is conducted within your clinic, there’s no need to share reimbursement with external teleretinal services. This maximizes your clinic’s financial benefits and supports the sustainable implementation of the screening program. Additionally, the automated reporting feature ensures that all necessary documentation is completed accurately and promptly, reducing the administrative burden on your staff.
The Benefits of Conducting Screenings in Primary Care
Integrating diabetic retinopathy screenings into your primary care practice offers numerous benefits for both your clinic and your patients. By conducting screenings during routine visits, you can significantly increase the screening rates among your diabetic patients, leading to earlier detection and intervention. This proactive approach can prevent vision loss and improve overall patient outcomes.
Furthermore, the real-time diagnosis capability of AEYE-DS allows you to provide immediate feedback to your patients. This not only enhances patient satisfaction but also fosters greater patient engagement in their own healthcare. Patients are more likely to adhere to follow-up appointments and treatment plans when they understand the importance of regular screenings and receive timely information about their condition.
Conclusion
Implementing AEYE-DS in primary care is straightforward and minimally disruptive to your existing workflows. Its seamless integration with EMR systems ensures efficient data management and enhances clinical decision-making. The system’s automated billing and reporting features streamline reimbursement processes, leveraging CPT code 92229 for financial viability and supporting your clinic’s sustainability. By offering a quick, on-the-spot diagnostic exam during routine visits, AEYE-DS increases screening rates, facilitates early detection, and improves patient outcomes. Embracing AEYE-DS not only enhances patient care but also positions your practice at the forefront of diabetic retinopathy detection and prevention, ultimately boosting quality measures and patient care.
